Iodo Niacin dissolves hemorrhage in vitreous. Drs. Abrahamson citation--don't have article
http://www.ncbi.nlm.nih.gov/pubmed/13372702 from article: The use of Iodine niacin preparations for the purpose of absorbing intraocular hemorrhages and strengthening damaged vascular walls has been known and used extensively for many years, but for some reason has recently fallen into more or less disrepute. In fact the treatment of recurrent and massive vitreal and retinal hemorrhages and vitreous floaters has been relatively unsatisfactory with the drugs at our disposal. Damrau found that the iodides did prevent artificial arteriosclerosis in rabbits in which it had been produced by high cholesterol feedings. Feinglatt and Ferguson in 1955 reported a series of 59 cases of generalized arteriosclerosis which were treated with Iodo-Niacin in full dosage for over a year with considerable therapeutic benefit and no iodism or adverse effects. In a controlled clinical investigation using comparable group on placebo medication, Iodo-Niacin tablets provided successful results in a series of 22 cases of retinal or vitreous hemorrhages and 89 of vitreous floaters. The tablets contain potassium Iodide 135 mg. and niacinamide hydroiodide 25 mg. The dosage was one tablet three times daily after meals. Iodo-Niacin was administered for periods of one to 13 months to an equal number of males and females between the ages of 18 and 87 years with various ocular conditions. The series included 12 cases of retinal hemorrhages and 89 of vitreous floaters. As compared with the control group, who received the placebo absorption of retinal hemorrhages, in the patients treated with Iodo-Niacin was much more rapid and complete. In a typical case of extensive retinal hemorrhages observed in the arteriosclerosis fundus of a patient with hypertension, Iodo-Niacin produced spectacular absorption in 18 days. In another case of angiospastic hemorrhages and edema involving the macula, substantial improvement was observed ophthalmoscopically after 25 days of treatment with Iodo-Niacin. The results have been recorded by before and after retinal photographs. Results in cases of vitreous hemorrhages were also dramatic. In four postoperative cataract cases, the condition cleared completely in three to four weeks. In a diabetic case which had resisted treatment for two years, the fundus was seen with 20/70 clarity after two months on Iodo-Niacin. Results were satisfactory in five other cases of vitreous hemorrhages due to diabetes or hypertension. Over 90 percent of the 89 patients with vitreous floaters who were treated with Iodo-Niacin showed subjective improvement and 50 percent showed objective improvement. Large vitreous floaters appeared to diminish in size and some of the fine dustlike opacities disappeared entirely. In several cases the vitreous floaters disappeared completely; in others they were reduced in size ophthalmoscopically after treatment with Iodo-Niacin for one to six months.
Niaco Iodine dissolves arteriosclerosis in eye arteries.